Cumberland Pharmaceuticals (CPIX) Debt Ratio (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Debt Ratio across 16 years of filings, most recently posting 0.07 for Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.07, down 1.49% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.07 (down 1.49% YoY), and the FY2025 annual result was 0.07, down 66.25% from the prior year.
• Debt Ratio came in at 0.07 for Q1 2026 at Cumberland Pharmaceuticals, up from 0.07 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.21 in Q3 2024 to a low of 0.07 in Q4 2025.
• The 5-year median for Debt Ratio is 0.17 (2022), against an average of 0.15.
• Across the five-year window, Debt Ratio soared 42.37% in 2024 and tumbled 66.25% in 2025, its largest moves.
• Cumberland Pharmaceuticals' Debt Ratio stood at 0.17 in 2022, then retreated by 10.33% to 0.16 in 2023, then climbed by 29.28% to 0.2 in 2024, then sank by 66.25% to 0.07 in 2025, then gained by 8.21% to 0.07 in 2026.
• The last three Debt Ratio figures came in at 0.07 (Q1 2026), 0.07 (Q4 2025), and 0.08 (Q3 2025), per Business Quant data.